Clinical Trials
2 trialsPapillomavirus Infections × Human Papillomavirus Recombinant Vaccine nonavalent × 90 days × Clear all
NCT03036930 2026-05-29
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04206813 2026-04-29
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Phase 4 Active not recruiting